Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibodies in Drug Discovery

Antibodies in Drug Discovery



Keynote Speakers


Sally Ward
Professor, Texas A&M Health Science Center

Overview

SELECTBIO is pleased to announce Antibodies in Drug Discovery 2017, will be held on 6 - 7 March 2017 in Cambridge, UK.

The event will form part of the multi-track conference, Advances in Drug Discovery, and will run alongside three additional tracks: Epigenetics in Drug Discovery, Academic Drug Discovery and Stem Cells in Drug Discovery. Attendees will benefit from unrestricted access to all four conference tracks.

Attracting researchers, academics and industry professionals working in antibody research, this track will fully explore the latest developments in the design and engineering of antibodies in relation to the burgeoning field of biotherapeutics. Topics to be addressed include, engineering challenges and techniques, new technologies and business hurdles when developing antibodies, the latest developments in autoimmune and infectious disease research.

If you work in antibody drug discovery research you will benefit from the expert knowledge of academic and industry leaders who are pushing the boundaries of antibody discovery, whilst networking with the technology providers who are enabling them to do so.

SELECTBIO is offering a limited number of student bursaries at this event. Find out more


Agenda Topics

  • Antibodies for New Targets
  • Antibody Drug Conjugates (ADCs)
  • Antibody Screening
  • Cancer - Immunology
  • Humanised Single Domain Antibodies for Research and Therapeutic Applications
  • Monoclonal Antibodies
  • Targeting Ion Channels with Biologics

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Distinguished Faculty

Leo James, , MRC Laboratory of Molecular Biology
Suzanne Cohen, , MedImmune
André Frenzel, , Leibniz Universität Hannover
Claire Hatty, Application Specialist, NanoTemper
Sai Reddy, Assistant Professor, ETH Zurich
Eugene Zhukovsky, Chief Scientific Officer, Biomunex Pharmaceuticals
Daniel Lightwood, Director, UCB Pharma
Christoph Merten, Principal Investigator, European Molecular Biology Laboratory
Mark Chiu, Principal Research Scientist, Janssen R&D Llc
Roman Kischel, Principal Scientist, Amgen Research
Dolores Cahill, Professor, University College Dublin
Nick Devoogdt, Professor, Free University Brussels (VUB)
Christian Schoneich, Professor, University of Kansas
Michael Hust, Professor, Technical University of Braunschweig
Ernesto Freire, Professor, Johns Hopkins University
Serge Muyldermans, Professor, Vrije Universiteit
Shamir Jacobino, Researcher, University Medical Center Utrecht
Simon Hufton, Section Head Molecular Immunology, National Institute for Biological Standard and Control (NIBSC)
Andrew Green, Senior Drug Discovery Specialist, Discoverx


Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks